108: Hydrocarbons
David D. Gummin
HISTORY AND EPIDEMIOLOGY
The modern world could not exist without hydrocarbons. Virtually everything we touch is either
coated with or made up primarily of hydrocarbon products. Organic chemistry originated during the
Industrial Revolution, evolving largely due to advances in coal tar technology. In the coking process,
bituminous (soft) coal is heated to liberate coal gas. This gas contains volatile hydrocarbons that can
be captured and separated into a variety of natural gases. The viscous residue left over from the
coking process forms coal tar, which can, in turn, be distilled into kerosene and other hydrocarbon
mixtures.
Over the years, petroleum has replaced coal tar as the principal source of commercial organic
compounds. Crude oil processing involves heating to a set temperature within processors that
separate (distill) hydrocarbon fractions by vapor (or boiling) point. Because of the relationship
between boiling point and molecular weight, distillation roughly divides hydrocarbons into like sized
molecules. The most volatile fractions come off early as gases, and these are used primarily as
heating fuels. The least volatile fractions (larger than about 10 or 12 carbons) are used chiefly for
lubricants or as paraffins, petroleum jelly, or asphalt. The remaining mid sized distillation fractions (5
to 10 carbons) are those most commonly used in combustion fuels and as solvents. Petroleum
distillates are used as chemical feedstocks and as precursors or intermediates in feedstock
production.
For decades in the United States, kerosene ingestion in children was a major public health
concern.121 Only through public education, consumer product safety initiatives, and modernization of
the use and distribution of cooking and heating fuels has this problem been largely eliminated. However, in the developing world, these same challenges have yet to be resolved, with large
numbers of children ingesting kerosene from poorly labeled and poorly secured
containers.1,18,19,46,63,93,109,125,137,159
Recent public attention and debate surrounds the potential for hydrocarbon exposures following
environmental spills. Even more controversial is the practice of “induced hydraulic fracturing” of rock
or shale, commonly called “fracking.” Fracking is performed on up to 60% of oil and gas wells drilled
today, to liberate pockets of trapped gas or oil from within the fractured rock.103,165 The intent is to
capture and collect trapped hydrocarbons, but some escape into nearby aquifers, thereby entering
water supplies or otherwise contaminating human environments. Critics are concerned about the
composition of the hydraulic fluids used, as these may be comprised mainly of methanol, ethylene
glycol, benzene, or other hydrocarbons. Components of these fluids are found in area groundwater,
with resultant risk of human exposure62,175 and untoward health effects.99
The true epidemiology of hydrocarbon exposure and illness is difficult to ascertain from available
data sources. But three populations appear to be at particular risk for hydrocarbon related illness.
These are children who suffer unintentional exposures, often ingestion with pulmonary aspiration;
workers with occupational exposures, often inhalational and dermal; and adolescents or young
adults who intentionally abuse solvents by inhalation. People in specific occupations who are at risk
for exposure include petrochemical workers, plastics and rubber workers, printers, laboratory
workers, painters, and hazardous waste workers. Most hydrocarbon exposures do not involve
ingestion, and most do not result in illness. Exposures may range from self-pumping gasoline, to
painting a spare bedroom, or to applying or removing fingernail polish. Because hydrocarbon
solvents are often volatile, inhalation is extremely common. Lipid solubility results in dermal
absorption when skin is exposed.65 Data from US poison centers suggest that about 30% of reported
exposures to hydrocarbons were in children younger than 6 years of age (Chap. 136). Largely not
captured in these data is an alarming rate of intentional misuse of volatile solvents by young people,
which is discussed in more depth in Chap. 84.
Most commonly encountered hydrocarbons are mixtures of compounds, often obtained from a
common petroleum distillation fraction. The many applications for these in consumer and household
products include paints and thinners, furniture polish, lamp oils, and lubricants. Table 108–1 lists
frequently encountered hydrocarbon compounds and their properties. This chapter focuses
principally on toxicity of hydrocarbons present in these commercially available mixtures. Individual
hydrocarbons are discussed only when they are commonly available in purified form, or when
specific xenobiotics result in unique toxicologic concerns.
TABLE 108–1. Classification and Viscosity of Common Hydrocarbons
View Large |
Favorite Table
CHEMISTRY
A hydrocarbon is an organic compound made up primarily of carbon and hydrogen atoms, typically
ranging from 1 to 60 carbon atoms in length. This definition includes products derived from plants
(pine oil, vegetable oil), animal fats (cod liver oil), natural gas, petroleum, or coal tar. There are two
basic types of hydrocarbon molecules, aliphatic(straight or branched chains) and cyclic (closed ring),
each with its own subclasses. The aliphatic compounds include the paraffins (alkanes, with a generic
formula CnH2n+2); theolefins (alkenes have one double bond and alkadienes have two double
bonds);acetylenes (alkynes) with at least one triple bond; and the acyclic terpenes (polymers of
isoprene, C5H8). Some aliphatic compounds have branches in which the subchain also contains
carbon atoms; both the chain and branches are essentially straight.
The cyclic hydrocarbons include alicyclic (three or more carbon atoms in a ring structure, with
properties similar to the aliphatics), and aromatic compounds, as well as the cyclic terpenes. The
alicyclics are further divided into cycloparaffins (naphthenes) such as cyclohexane, and
the cycloolefins (two or more double bonds) such as cyclopentadiene.
Saturated hydrocarbons contain carbon atoms that exist only in their most reduced state. This
means that each carbon is bound to either hydrogen or to another carbon, with no double or triple
bonds present. Conversely, unsaturated compounds are those with hydrogens removed, in which
double or triple bonds exist.
Solvents are a heterogenous class of xenobiotics used to dissolve and provide a vehicle for delivery
of other xenobiotics. The most common industrial solvent is water. The common solvents most
familiar to toxicologists are organic solvents (containing one or more carbon atoms), and most of
these are comprised of hydrocarbons. Most are liquids in the conditions under which they are used.
Specifically named solvents (Stoddard solvent, white naphtha, ligroin) represent mixtures of
hydrocarbons emanating from a common petroleum distillation fraction.
Aromatic hydrocarbons are divided into the benzene group (one ring), naphthalene group (two
rings), and the anthracene group (three rings). Polycyclic aromatic hydrocarbons(polynuclear
aromatic hydrocarbons) have multiple, fused benzenelike rings. Aromatic organic compounds may
also be heterocyclic (where oxygen or nitrogen substitutes for carbon in the ring). Structurally, all of
these molecules are flat, with reactive electron clouds above and below the ring.
The cyclic terpenes are the principal components of the variety of plant-derived essential oils (Chap.
43), often providing color, odor, and flavor. Limonene in lemon oil, menthol in mint oil, pinene in
turpentine, and camphor are all terpenes.
Physical properties of hydrocarbons vary by the number of carbon atoms and by molecular structure.
Unsubstituted, aliphatic hydrocarbons that contain up to 4 carbons are gaseous at room
temperature, 5 to 19carbon molecules are liquids, and longer-chain molecules tend to be tars or
solids. Branching of chains tends to destabilize intermolecular forces, so that less energy is required
to separate the molecules. The result is that, for a given molecular size, highly branched molecules
have lower melting and boiling points and tend to be more volatile.
The various definitions of paraffin warrant discussion. In chemistry, paraffin is a general term for any
alkane. In North American common use, paraffin describes either medicinal paraffin or paraffin
wax. Medicinal paraffin is the same as mineral oil, a viscous mixture of longer-chained alkanes
(typically 15–50 carbon atoms per molecule) derived from a petroleum source. The molecules in
mineral oil exhibit considerable branching, making it a viscous liquid at room temperature and
pressure. Molecules in paraffin wax are nearly identical to these in size, but less branching increases
the number of intermolecular interactions, forming a waxy/solid at room temperature. Outside North
America, the termparaffin often refers to kerosene—a mixture of medium-chain alkanes typically
used for lighting and heating.
Gasoline is a mixture of alkanes, alkenes, naphthenes, and aromatic hydrocarbons, predominantly 5
to 10 carbon atoms in size. Gasoline is separated from crude oil in particular distillation fractions and
then usually blended with several other fractions in refinery processors. More than 1500 individual
molecular species may be present in commercial grades, but most analytical methods isolate only
150 to 180 constituent compounds in gasoline. Notably, n-hexane is present at up to 6%, and
benzene is present between 1% and 6%, depending on the origin and processing technique. A
number of additives may go into the final formulation: alkyl leads, ethylene dichloride, and ethylene
dibromide in leaded gasoline, and oxygenates such as methyl t-butyl ether (MTBE), as well as
methanol and ethanol.
Organic halides contain one or more halogen atoms (fluorine, chlorine, bromine, iodine) usually
substituted for a hydrogen atom in the parent structure. Examples include chloroform,
trichloroethylene, and the freons.
Oxygenated hydrocarbons demonstrate toxicity specific to the oxidation state of the carbon, as well
as to the atoms adjacent to it (the “R” groups). The alcohols are widely used as solvents in industry
and in household products. Their toxicity is discussed inChaps. 80 and 109. Ethers contain an
oxygen atom bound on either side by a carbon atom. Acute toxicity from ethers tends to mirror that
of the corresponding alcohols.Aldehydes and ketones contain one carbon–oxygen double bond (C =
O), the former at a terminal carbon, the latter somewhere in the middle. Organic acids, esters,
amides, andacyl halides represent more oxidized states of carbon; human toxicity is agent specific.
Phenols consist of benzene rings with an attached hydroxyl (alcohol) group. The parent compound,
phenol, has only one hydroxyl group attached to benzene. The toxicity of phenol can be dramatically
altered by addition of other functional groups to the benzene ring (Chap. 104). Cresols, catechols,
and salicylate are examples of substituted phenols.
A variety of amines, amides, nitroso and nitro compounds, as well as phosphates, sulfites, and
sulfates are used commercially and industrially. The addition of these functional groups to
hydrocarbons dramatically alters the characteristics, including the toxicity of the compound.
PHARMACOLOGY
The effects of hydrocarbons on humans are chiefly related to interactions with lipid bilayers in
cellular membranes. Inhaled hydrocarbon vapor depresses consciousness. As such, acute central
nervous system (CNS) toxicity from occupational overexposure or recreational abuse parallels the
effect of administering an inhaled general anesthetic. The concentration of volatile anesthetic that
produces loss of nociception in 50% of patients defines the minimum alveolar concentration (MAC)
required to induce anesthesia. Similarly, inhaled solvent vapor produces unconsciousness in 50% of
subjects, when the partial pressure in the lung reaches its median effective dose (ED50). The ED50 in
occupational terms is effectively the same as the MAC in anesthesiology terms (Chap. 68). Virtually
all patients will be anesthetized when the partial pressure is raised 30% above the MAC (MAC ×
1.3). If ventilation is not supported, death typically occurs when the concentration reaches two to four
times the MAC.85 Dose–response curves suggest that essentially no individual will be rendered
unconscious by an inhaled dose 30% below the MAC. Nonetheless, impaired cognitive and motor
function may occur at much lower doses.23
The physical property of an inhaled anesthetic that correlates most closely with its ability to
extinguish nociception is its lipid solubility. Inhalational exposure to lipid-soluble solvents, such as
aromatic, aliphatic, or chlorinated hydrocarbons, is more likely to cause acute and chronic CNS
effects than exposure to water-soluble hydrocarbons such as alcohols, ketones, and esters. The
Meyer-Overton hypothesis, proposed more than 100 years ago, implies that an anesthetic dissolves
into some critical lipid compartment of the CNS, causing inhibition of neuronal transmission.
According to this hypothesis, the target structure for general anesthetics is the neuronal lipid
membrane itself.66
Unfortunately, this hypothesis is likely too simplistic. Numerous protein receptor interactions also
occur. Halothane, isoflurane, sevoflurane, enflurane, and desflurane inhibit fast sodium
channels.117 Toluene, trichloroethylene, perchloroethylene, and others inhibit neuronal calcium
currents.114,135 The halogenated hydrocarbons increase the outward potassium rectifying
current.136 Specific ligand-receptor interactions occur,43such as the inhibition of receptor function at
nicotinic,167 and at glutamate receptors,42 as well as enhancement of type-A γ-aminobutyric acid
(GABAA) and glycine receptor currents.17 Independent of other mechanisms, halogenated
hydrocarbons appear to decrease exocytosis of neuronal synaptic vesicles.68
Pharmacodynamic properties of inhaled hydrocarbons and other volatile xenobiotics (Chap. 68)
suggest some receptor–ligand interaction, and a growing body of evidence suggests that the MeyerOverton hypothesis cannot explain the many neurochemical activities demonstrated by this broad
class of xenobiotics.70 Perhaps a more elegant approach to the lipid bilayer interaction has been
termed the “modern lipid hypothesis.” The hypothesis is thermodynamically derived, purporting an
increase in lateral pressure on protein receptors within the neuronal bilayer. Lateral pressure leads
to conformational changes in membrane ion channels, modulating the capacity for activation.32 While
this hypothesis is mechanistically plausible and thermodynamically defensible, no in vitro or in vivo
work has yet substantiated it. Thus, to date, no single mechanism fully explains the pharmacologic
and toxicologic activity of volatile hydrocarbons on neuronal tissues.
TOXICOKINETICS
Hydrocarbons are variably absorbed into human systems by ingestion, inhalation, or dermal routes.
Human toxicokinetic data are lacking for most of these xenobiotics, so much of our understanding
derives from in vitro studies and animal research. Partition coefficients, in particular, are useful
predictors of the rate and extent of the absorption and distribution of hydrocarbons into tissues. A
partition coefficient for a given chemical species is the ratio of concentrations achieved between two
different media at equilibrium. The blood-to-air, tissue-to-air, and tissue-to-blood coefficients directly
relate to the pulmonary uptake and distribution of hydrocarbons. The tissue-to-blood partition
coefficient is commonly derived by dividing the tissue-to-air coefficient by the blood-to-air
coefficient.55,120 The higher the value, the greater the potential for distribution into tissue.Table 108–
2 lists partition coefficients for commonly encountered hydrocarbons. Where human data are limited,
rat data is presented in the table, because human and rat data often correlate.120
TABLE 108–2. Kinetic Parameters of Selected Hydrocarbons
View Large |
Favorite Table
Inhalation is a major route of exposure for most volatile hydrocarbons. Most cross the alveolar
membrane by passive diffusion. The driving force is the difference in vapor concentration between
the alveolus and the blood. The absorbed dose is determined by the air concentration, duration of
exposure, minute ventilation, and the blood-to-air partition coefficient. Hydrocarbons that are highly
soluble in blood and tissues are readily absorbed, and blood concentrations rise rapidly following
inhalation exposure. While aromatic species are generally well absorbed, absorption of aliphatic
hydrocarbons varies by molecular weight: aliphatic hydrocarbons with between 5 and 16 carbons are
readily absorbed through inhalation, whereas those with more than 16 carbons are less extensively
absorbed.
Absorption of aliphatic hydrocarbons through the digestive tract is inversely related to molecular
weight, ranging from complete absorption at lower molecular weights, to approximately 60% for C-14
hydrocarbons, 5% for C-28 hydrocarbons, and essentially no absorption for aliphatic hydrocarbons
with more than 32 carbons. Oral absorption of aromatic hydrocarbons with between 5 and 9 carbons
ranges from 80% to 97%. Oral absorption of aromatics with more than 9 carbons is poorly
characterized, as data are lacking.
While the skin is a common area of contact with solvents, the dose of dermally absorbed
hydrocarbons is quite small relative to that through other routes such as inhalation. The skin is
comprised of both hydrophilic (proteinaceous portion of cells) and lipophilic (cell membranes) regions
(Chap. 18). While many hydrocarbons can remove lipids from the stratum corneum, permeability is
not simply the result of lipid removal; permeability also increases with hydration of the skin. The rate
of skin absorption is highest when xenobiotics have a water-to-lipid partition coefficient near one.
Solvents that contain both hydrophobic and hydrophilic moieties (eg, glycol ethers,
dimethylformamide, dimethylsulfoxide) are particularly well absorbed through skin. Other factors that
determine penetration across the skin include the thickness of the skin layer, the difference in
concentration of the solvent on either side of the epithelium, the diffusion constant, and skin integrity
(ie, normal vs. cut or abraded).
The dose absorbed through skin is proportional to the exposed surface area and the duration of
contact. Although highly volatile compounds may have a short duration of skin contact because of
evaporation, skin absorption can also occur from contact with hydrocarbon vapor. In studies with
human volunteers exposed to varying concentrations of hydrocarbon vapors, the dermal dose
accounted for only 0.1% to 2% of the inhalation dose. With massive exposure (eg, whole-body
immersion), dermal absorption may contribute significantly to toxicity. Significant dermal absorption
with resultant toxicity is described with carbon tetrachloride,74 tetrachloroethylene,65 and phenol.91
Once absorbed into the central compartment, hydrocarbons are distributed to target and storage
organs based on their tissue-to-blood partition coefficients and on the rate of perfusion of the tissue
with blood. During the onset of systemic exposure, hydrocarbons accumulate in tissues that have
tissue/blood coefficients greater than 1 (eg, for toluene, the fat-to-blood partition coefficient is
60). Table 108–2 lists the distribution half-lives of selected hydrocarbons.
Hydrocarbons can be eliminated from the body unchanged, for example, through expired air, or can
be metabolized to more polar compounds, which are then excreted in urine or bile. Table 108–2 lists
the blood elimination half-lives (for first-order elimination processes) and metabolites of selected
hydrocarbons. Some hydrocarbons are metabolized to toxic compounds (eg, methylene chloride,
carbon tetrachloride, n-hexane, methyl-n-butyl ketone). The specific toxicities of these metabolites
are discussed later in this chapter.
PATHOPHYSIOLOGY AND CLINICAL FINDINGS
Respiratory
Several factors are classically associated with pulmonary toxicity after hydrocarbon ingestion. These
include specific physical properties of the xenobiotics ingested, the volume ingested, and the
occurrence of vomiting. Physical properties of viscosity, surface tension, and volatility are primary
determinants of aspiration potential.
Dynamic (or absolute) viscosity is the measurement of the ability of a fluid to resist flow. This
property is measured with a rheometer and is typically given in units of pascal-seconds. More
frequently, engineers work with kinematic viscosity, measured in square millimeters per second, or
centistokes. Dynamic viscosity is converted to kinematic viscosity by dividing the dynamic viscosity
by the density of the fluid. An older system for measuring viscosity was initially popularized by the
petroleum industry and expresses kinematic viscosity in units of Saybolt Universal seconds (SUS).
Unfortunately, many policy statements were developed in an era when SUS units were popular, and
many still describe viscosity in SUS units. Various look-up tables and calculators are available to
convert kinematic viscosity to SUS units. Table 108–1 shows kinematic viscosity of common
hydrocarbons, measured in SUS. A unit conversion approximation is given in the table’s footnote.
Hydrocarbons with low viscosities (<60 SUS; eg, turpentine, gasoline, naphtha) have a higher
tendency for aspiration in animal models. The US Consumer Products Safety Commission issued a
rule in 2001, requiring child-resistant packaging for products that contain 10% or more hydrocarbon
by weight and have a viscosity less than 100 SUS.
Surface tension is a cohesive force generated by attraction due to the Van der Waals forces
between molecules. This influences adherence of a liquid along a surface (“its ability to creep”). The
lower the surface tension, the more effectively the liquid will creep, producing a higher aspiration
risk.57
Volatility is the tendency for a liquid to become a gas. Hydrocarbons with high volatility tend to
vaporize, displace oxygen, and potentially lead to transient hypoxia.
Early reports conflicted in their attempts to relate risk of pulmonary toxicity (1) to the amount of
hydrocarbon ingested or (2) to the presence or absence of vomiting. One prospective study
addressed both these variables. The cooperative kerosene poisoning (COKP) study was a
multicenter study that enrolled 760 patients with hydrocarbon ingestion. Of these, 409 individuals
could provide an estimate of the amount ingested. Patients who reportedly ingested more than 30
mL had a 52% chance of developing pulmonary complications, compared with 39% of those who
ingested less than 10 mL. Risk of central nervous complications was 41%, compared with 24% using
the same criterion. There was a 53% incidence of pulmonary toxicity when vomiting occurred,
compared with 37% when there was no history of vomiting.121 While this knowledge may help modify
the index of suspicion regarding possible pulmonary toxicity, none of these parameters is completely
predictive. Severe hydrocarbon pneumonitis may occur after ingestion of “low-risk”
hydrocarbons.131 Patients may develop severe lung injury after low-volume (<5 mL) ingestions, as
well as after ingestions with no history of coughing, gagging, or vomiting.8
It is widely held that aspiration is the main route of injury from ingested simple hydrocarbons. The
mechanism of pulmonary injury, however, is not fully understood. Intratracheal instillation of 0.2
mL/kg of kerosene causes physiologic abnormalities in lung mechanics (decreased compliance and
total lung capacity) and pathologic changes such as interstitial inflammation, polymorphonuclear
exudates, intraalveolar edema and hemorrhage, hyperemia, bronchial and bronchiolar necrosis, and
vascular thrombosis.61These changes most likely reflect both direct toxicity to pulmonary tissue and
disruption of the lipid surfactant layer.171
Most patients who develop pulmonary toxicity following hydrocarbon ingestion will have an initial
episode of coughing, gagging, or choking. This usually occurs within 30 minutes after ingestion and
is presumptive evidence of aspiration. The majority of patients who have respiratory signs and
symptoms in addition to the initial history of gagging, choking, and coughing develop radiographic
pneumonitis. Pulmonary toxicity may manifest as crackles, rhonchi, bronchospasm, tachypnea,
hypoxemia, hemoptysis, acute respiratory distress syndrome (hemorrhagic or nonhemorrhagic), or
respiratory distress. Cyanosis develops in approximately 2% to 3% of patients. This may result from
simple asphyxiant effects from volatilized hydrocarbons, from ventilation–perfusion mismatch, or,
rarely, from methemoglobinemia (aniline, nitrobenzene, or nitrite-containing hydrocarbons). Clinical
findings often worsen over the first several days but typically resolve within a week. Death is
distinctly uncommon and typically occurs after a severe, progressive respiratory insult marked by
hypoxia, ventilation–perfusion mismatch, and barotrauma.75,92,179
Intravenous (IV), subcutaneous, and even intrapleural injection of hydrocarbons are
reported.45,129,163 Severe hydrocarbon pneumonitis may occur following IV exposure. Animal
experiments show that intravascular hydrocarbons injure the first capillary bed encountered.127,173 The
clinical course after IV hydrocarbon injection is comparable to that of aspiration injury.
Radiographic evidence of pneumonitis develops in 40% to 88% of patients admitted following
aspiration.16,44,115 Findings can develop as early as 15 minutes or as late as 24 hours after exposure
(Fig. 108–1).22,54,121,164 Chest radiographs performed immediately on initial presentation are not useful
in predicting infiltrates in either symptomatic or asymptomatic patients.8 Ninety percent of patients
who develop radiographic abnormalities do so by 4 hours postingestion.22 Clinical signs of
pneumonia (eg, crackles, rhonchi) are evident in 40% to 50% of patients.44 A small percentage (<5%)
are completely asymptomatic after a period of observation, yet to have radiographic findings.8
(A)
Initial: Patchy densities appear in the basilar areas of both lung fields with increased interstitial markings and
peribronchial thickening.
View Full Size |
Favorite Figure | Download Slide (.ppt)
(B)
Day 2: More extensive diffuse alveolar infiltrates are apparent.
View Full Size |
Favorite Figure | Download Slide (.ppt)
(C)
Day 6: Dense consolidation and atelectasis are evident in the right lower lobe. (Used with permission of Nancy
Genieser, MD, Professor of Radiology, New York University.)
View Full Size |
Favorite Figure | Download Slide (.ppt)
Specific radiologic findings include perihilar densities, bronchovascular markings, bibasilar infiltrates,
and pneumonic consolidation.58 Right-sided involvement occurs in 75% of cases and bilateral
involvement in approximately 50%. Upper-lobe involvement is uncommon. Pleural effusions develop
in 3% of cases, with one-third appearing within 24 hours.100 Pneumothorax, pneumomediastinum,
and pneumatoceles occur uncommonly.10,20,78 Initial radiographs after ingestion may reveal two liquid
densities in the stomach, known as the “double-bubble” sign. This represents an air–fluid
(hydrocarbon or water) and a hydrocarbon–water interface, as the hydrocarbon is not miscible with
gastric (aqueous) fluid and may have a specific gravity less than that of water.38
Radiographic resolution does not correlate with clinical improvement but rather lags behind by
several days to weeks. There are few reports of long-term follow-up on patients with hydrocarbon
pneumonitis.64,154 Frequent respiratory tract infections are described after hydrocarbon pneumonitis,
but these studies are not well controlled.54,157 Delayed formation of pneumatoceles may
occur.20,78 Bronchiectasis and pulmonary fibrosis are reported but appear to be uncommon.60,124 In one
study, 82% of patients examined 8 to 14 years after hydrocarbon-induced pneumonitis had
asymptomatic minor pulmonary function abnormalities. The abnormalities were consistent with
small-airway obstruction and loss of elastic recoil. The authors hypothesized that this group may be
predisposed to chronic obstructive pulmonary disease.64
Cardiac
The most concerning cardiac effect from hydrocarbon exposure is precipitation of dysrhythmias
through myocardial sensitization.110 Malignant dysrhythmias may occur after exposure to high
concentrations of volatile inhalants or inhaled anesthetics. Such events are described with all
classes of hydrocarbons, but halogenated compounds are most frequently implicated, followed by
aromatic compounds.13,126 Atrial fibrillation, ventricular tachycardias, junctional rhythms, ventricular
fibrillation, and cardiac arrest are reported.29,105,111,126 This is termed the “sudden sniffing death
syndrome.”14 Prolongation of the QT interval in some cases raises additional concern for the
development of torsade de pointes.14,133
Cardiac sensitization is incompletely understood.43,110,134 Halothane and isoflurane inactivate sodium
channels,142 whereas chloroform and others attenuate potassium efflux through voltage-gated
channels.133 Sensitization may be mediated by slowed conduction velocity through membrane gap
junctions. Dephosphorylation of connexin-43 results in a conformational change that increases gap
junctional resistance. Halocarbons, in the presence of epinephrine, cause dephosphorylation of this
gap junction protein, thereby increasing resistance and slowing conduction velocity in myocardial
tissue.76
Any route of exposure to hydrocarbons may result in cardiotoxicity. Classically, sudden death follows
an episode of sudden exertion, presumably associated with an endogenous catecholamine
surge.14 Tachydysrhythmias, cardiomegaly, and myocardial infarction are rarely reported after
ingestion of hydrocarbons.72,144 A retrospective follow-up cohort of exposed methylene chloride
workers did not find evidence of excess long-term cardiac disease.116
Central Nervous System
Transient CNS excitation may occur after acute hydrocarbon inhalation or ingestion, but more
commonly, CNS depression or general anesthesia occurs.44 In cases of aspiration, hypoxemia from
pulmonary damage may contribute to CNS depression.95,174 Coma and seizures are reported in 1% to
3% of cases.115,124,178 Chronic occupational exposure or volatile substance use may lead to a chronic
neurobehavioral syndrome, the painter’s syndrome, most notably described after toluene
overexposure. Clinical features include ataxia, spasticity, dysarthria, and dementia, consistent with
leukoencephalopathy.50,51,52, and 53 Autopsy studies of the brains of chronic toluene abusers show
atrophy and mottling of the white matter, as though the lipid-based myelin were dissolved away.
Microscopic examination shows a consistent pattern of myelin and oligodendrocyte loss with relative
preservation of axons.84 Animal models of toluene poisoning reveal norepinephrine and dopamine
depletion. The severity and reversibility of this syndrome depends on the intensity and duration of
toluene exposure.132 Infrequent exposure may produce no clinical neurologic signs, whereas severe
(daily) use can lead to significant neurologic impairment after as little as 1 year, but more commonly
after 2 to 4 years of continuous exposure. The specific cognitive and neuropsychological findings in
toluene-induced dementia have been termed a white matter dementia.50,51, and 52
Initial findings of white matter dementia include behavioral changes, impaired sense of smell,
impaired capacity to concentrate, and mild unsteadiness of hand movements and gait. Further
exposure leads to slurred speech, head tremor, poor vision, deafness, stiff-legged and staggering
gait, and subsequent dementia. Physical findings may include nystagmus, ataxia, tremor, spasticity
with hyperreflexia, plantar extension, deafness, impaired vision, and a broad-based, staggering gait.
An abnormal brainstem auditory-evoked response appears to be a sensitive indicator of tolueneinduced CNS damage. The electroencephalogram can show mild, diffuse slowing. Computed
tomography in severe cases shows mild-to-moderate cerebellar and cortical atrophy. Magnetic
resonance imaging (MRI) findings are consistent with white matter disease. Most cases show clinical
improvement after 6 months of abstinence, although with moderate to severe abuse, improvement
may be incomplete. While toluene abuse is addicting, withdrawal or abstinence syndrome is
surprisingly uncommon and, when present, appears relatively benign.50,51, and 52
Exposures in the occupational setting are rarely as extreme as those that occur with intentional
volatile substance misuse. Given the significantly lesser exposures, the findings among workers
overexposed to solvent concentrations above permissible exposure limits are often subclinical and
detected primarily through neurobehavioral testing. In rare cases, however, a worker may be acutely
overexposed to solvent concentrations that can produce acute CNS depression. Repeated,
symptomatic overexposures over a protracted period of time have the potential to lead to a chronic
encephalopathy, as evident from the experience with solvent abusers.51
Peripheral Nervous System
Peripheral neuropathy is well described following occupational exposure to n-hexane or methyl-nbutyl ketone (MnBK).25 This axonopathy results from a common metabolic intermediate, 2,5hexanedione. The mechanism by which this intermediate causes peripheral neuropathy probably
relates to decreased phosphorylation of neurofilament proteins, with disruption of the axonal
cytoskeleton. Methyl ethyl ketone may exacerbate this neurotoxicity, probably by interfering with
metabolic pathways of n-hexane and MnBK.7,130 Other organic solvents, such as carbon disulfide,
acrylamide, and ethylene oxide, may cause a similar peripheral axonopathy.59 Cranial and peripheral
neuropathies are reported after acute and chronic exposure to trichloroethylene
(TCE).77,90,151Pathologically, TCE appears to induce a myelinopathy.48,59
TCE exposure is associated with trigeminal neuralgia.34,47,90 Symptoms can develop within 12 hours of
a single intense exposure and persist for many years.48 Trigeminal nerve damage was documented
by evoked potentials following 15 minutes of TCE inhalation.90 Some evidence suggests that
decomposition products or impurities in TCE may be responsible for cranial neuropathy.34,47,85
Axonopathy from MnBK or n-hexane exposure typically begins in the distal extremities and
progresses proximally (a classic, “dying-back” neuropathy) (Chap. 24). Exposure to one of these
hydrocarbons should be considered in the differential diagnosis of the patient with Guillain-Barré
syndrome (GBS), although sensory findings are present with MnBK and absent in GBS.140 The
longest axons appear to be affected initially, so that the patient manifests a “length-dependent
polyneuropathy.” With discontinuation of exposure many of the effects reverse over weeks to
months.69,80,122,177 Alternatively, the phenomenon of “coasting” may occur, in which neuropathy
progresses for a time (weeks to months) after discontinuation of the toxic insult.140 A reversible
peripheral neuropathy occurred in 40% of chronic toluene abusers and was characterized by severe
motor weakness without sensory deficits or areflexia.150 It is unclear whether the toluene in this series
might have been contaminated by n-hexane or MnBK.7
Gastrointestinal
Hydrocarbons irritate gastrointestinal mucous membranes. Nausea and vomiting are common after
ingestion. As discussed earlier, vomiting may increase the risk of pulmonary
toxicity.113,115 Hematemesis was reported in 5% of cases in one study,113 and gastrointestinal
ulcerations are reported in animal studies81.
Hepatic
The chlorinated hydrocarbons (Table 108–1) and their metabolites are hepatotoxic. In most cases,
activation occurs via a phase I reaction to form a reactive intermediate (Chap. 13). In the case of
carbon tetrachloride, this intermediate is the trichloromethyl radical. This radical forms covalent
bonds with hepatic macromolecules and may initiate lipid peroxidation.27 Carbon tetrachloride causes
centrilobular necrosis after inhalational, oral, or dermal exposure.102 Hepatotoxicity in animals has
been ranked for common hydrocarbons as follows: carbon tetrachloride is greater than benzene, and
trichloroethylene is greater than pentane.172 Vinyl chloride is a liver carcinogen, and trichloroethylene,
tetrachloroethylene, and 1,1,1-trichloroethane are considered less acutely hepatotoxic than vinyl
chloride.102 Hepatotoxicity rarely follows ingestion of petroleum distillates.73 Hepatic injury, manifested
as aminotransferase elevation and hepatomegaly, is usually reversible except in massive exposures.
Renal
Halogenated hydrocarbons such as chloroform, carbon tetrachloride, ethylene dichloride,
tetrachloroethane, 1,1,1-trichloroethane, and TCE are nephrotoxic. Acute kidney injury (AKI) and
distal renal tubular acidosis occur in some painters and volatile-substance abusers.15 Toluene
causes a renal tubular acidosislike syndrome (see Toluene later in the chapter).
Hematologic
Hemolysis has been sporadically reported to occur following hydrocarbon ingestion.2,6,148One
retrospective study of 12 patients showed hemolysis in three individuals and disseminated
intravascular coagulation in another.6 Although one patient required transfusion, hemolysis is usually
mild and typically does not require red blood cell transfusion (also see discussion of the effects of
benzene on bone marrow, under Benzene later in the chapter).
Immunologic
Hydrocarbons disturb the integrity of membrane lipid bilayers, causing swelling and increased
permeability to protons and other ions. This alters the structural and functional integrity of the
membrane. Changes in the lipid composition of the membrane occur, and membrane
lipopolysaccharides and proteins are disturbed.138 Resultant toxicity may directly destroy capillary
endothelium.26 Additionally, there appears to be significant basement membrane dysfunction, and
this is postulated to underlie both alveolar and glomerular toxicity of hydrocarbons.145 Immune
mechanisms may account for basement membrane dysfunction in chronic exposures. Hydrocarbon
exposure is suggested as one possible cause of the Goodpasture syndrome (immune dysfunction
causing both pulmonary damage and glomerulonephritis),24 although the association is not widely
accepted. Measurable changes in immune function occur after hydrocarbon exposure,12but our
knowledge of any clinical relevance is incomplete.
Dermatologic
Most hydrocarbon solvents cause nonspecific irritation of skin and mucous membranes. Repeated,
prolonged contact can dry and crack the skin. The mechanism of dermal injury appears to be
defatting of the lipid layer of the stratum corneum. Up to 9% of workers may develop eczematous
lesions from dermal contact.176 Limonene and turpentine contain sensitizers that can rarely result in
contact allergy (Chap. 18).
Contact dermatitis and blistering may progress to partial- and even full-thickness burns.67Severity is
proportional to duration of exposure. Hydrocarbons are irritating to skin. Acute, prolonged exposure
can cause dermatitis and even full-thickness dermal damage.67Chronic dermal exposure to kerosene
or diesel fuel can cause oil folliculitis.39,162 A specific cutaneous lesion called chloracne is associated
with exposure to chlorinated aromatic hydrocarbons with highly specific stereochemistry such as
dioxins and polychlorobiphenyls.
Soft tissue injection of hydrocarbon is locally toxic, leading to necrosis.45 Secondary cellulitis,
abscess formation, and fasciitis can occur. Infectious complications are treated by meticulous wound
care, with surgical débridement as necessary. A particularly destructive injury involves high-pressure
injection gun injury. These injuries typically involve the extremities, with high-pressure injection of
grease or paint into the fascial planes and tendon sheaths. Emergent surgical débridement is
necessary in most of these cases.49,107
HYDROCARBONS WITH SPECIFIC AND UNIQUE
TOXICITY
n-Hexane
Hexane is a six-carbon simple aliphatic hydrocarbon. It is a constituent of some brake-cleaning
fluids, rubber cement, glues, spray paints, coatings, and silicones. Outbreaks ofn-hexane–related
neurotoxicity have occurred in printing plants, sandal shops, furniture factories, and automotive
repair shops.35 Human exposure occurs primarily by inhalation. Both n-hexane and MnBK are wellknown peripheral neurotoxins that cause a classic “dying-back” peripheral polyneuropathy,
beginning in a “stocking-glove” distribution.36Neurotoxicity does not appear to be directly caused by
the parent compounds but results from a common metabolic intermediate—2,5-hexanedione.
Toxicity appears related to the ability of this intermediate to form a ringed pyrrole structure, which
causes decreased phosphorylation of neurofilament proteins, disrupting the axonal
cytoskeleton.59 Similar five- and seven-carbon species do not induce similar neurotoxicity, except
those that are direct precursor intermediates in the metabolic pathway producing 2,5hexanedione59,152(Fig. 108–2).
FIGURE 108–2.
The metabolism of both organic solvents n-hexane and methyl n-butyl ketone produces the same common
metabolite, 2,5-hexanedione.
View Full Size |
Favorite Figure | Download Slide (.ppt)
Methylene Chloride
Methylene chloride is commonly found in paint removers, cleansers, degreasers, and aerosol
propellants. Like other halogenated hydrocarbons, it can rapidly induce general anesthesia by
inhalation or ingestion. Unlike other hydrocarbon agents, methylene chloride and similar one carbon
halomethanes such as methylene dibromide are metabolized by liver P450 2E1 mixed-function
oxidase to carbon monoxide. Significant, delayed, and prolonged carboxyhemoglobinemia can
occur3,123 (Table 108–2 and Chap. 125).
Carbon Tetrachloride
Carbon tetrachloride (CCl4), although not actually a hydrocarbon, has been used as an industrial
solvent and reagent. Its use in the United States has declined dramatically since recognition of its
toxicity caused the Environmental Protection Agency to restrict its commercial use. Absorption
occurs by all routes, including dermal. CCl4 is an irritant to skin and mucous membranes and gastric
mucosa when ingested. As in the case of other halogenated hydrocarbons, aspiration can result in
pneumonitis, and systemic absorption may result in ventricular dysrhythmias.
CCl4 exposures are hepatotoxic and nephrotoxic. Both occur more commonly with repetitive
occupational exposure.74,155 Toxicity follows phase-I dehalogenation of the parent compound, which
produces free radicals and causes lipid peroxidation and the production of protein
adducts.27 Localization of specific phase I hepatic enzymes in the centrilobular area of the liver
results in regionalized (zone 3) centrilobular injury after CCl4exposure (Chap. 23). Hepatotoxicity is
typically manifested as reversible aminotransferase concentration elevations with or without
hepatomegaly. Cirrhosis is reported in both animal models and in humans with prolonged excessive
exposures. Nephrotoxicity is less studied but may result from a similar mechanism. CCl4 is a
suspected human carcinogen.108
Trichloroethylene
TCE is a commonly used industrial solvent, cleanser, and degreaser. Systemically absorbed TCE,
as might occur in the occupational setting, may competitively inhibit aldehyde dehydrogenase.
Concomitant ethanol consumption may result in a disulfiramlike reaction that has been termed
“degreaser’s flush”147 (Chap. 79).
TCE was used for years as a general anesthetic, and hundreds of disposal sites in the United States
remain sources of ongoing human exposure. The use of TCE as a general anesthetic was
abandoned because of associated acute cardiotoxicity. TCE is also hepatotoxic, neurotoxic, and
nephrotoxic in humans and animals. TCE exposure is linked to the development of
neurodegenerative diseases, such as parkinsonism.56 Evidence suggests that TCE is a human
carcinogen.112,118,146
Benzene
Benzene is hematotoxic and associated with acute hemolysis or with the delayed development of
aplastic anemia and acute myelogenous leukemia.4,86,101,119 Other aromatic hydrocarbons that are
reported to cause similar hematologic effects most likely are contaminated with benzene. An excess
risk of hematologic toxicity has not been demonstrated in groups with long-term exposure to toluene,
xylene, or other aromatic hydrocarbons.9,40,128,166,170 Other hematologic malignancies also may be linked
to benzene, including chronic myelocytic leukemia, myelodysplastic syndromes, and
lymphoma.156 Chromosomal changes are believed to provide a marker for carcinogenicity.161 Because
of the carcinogenic risk, most benzene-based solvents have been removed from the US market, and
the Occupational Safety and Health Administration has limited the permissible worker exposure
concentration to 1 ppm.
Toluene
Toluene has essentially replaced benzene as the primary organic solvent in many commercial
products. Many oil paints and stains primarily contain toluene as solvent. As such, it is readily
available and readily abused as an inhalant. The CNS sequelae of chronic solvent inhalation are
most frequently related to chronic toluene exposure.
Chronic toluene abuse can also cause a syndrome that resembles transient distal renal tubular
acidosis (RTA).153,168 Although the mechanism is incompletely understood, the acidosis results in
great part from the urinary excretion of hippuric acid (Table 108–2).33,79Renal potassium loss may be
severe and can result in symptomatic hypokalemia.79Clinical findings are a hyperchloremic metabolic
acidosis, hypokalemia, and aciduria. Typically an associated transient azotemia occurs, as well as
proteinuria and an active urine sediment.150,168 Some also report a proximal RTA, or the Fanconi
syndrome.106,168A metabolic acidosis resulting from the metabolism of toluene to benzyl alcohol
through alcohol dehydrogenase to benzoic acid may be an adequate explanation for the serum and
urine acid–base disturbances.
Pine Oil and Terpenes
Pine oil is an active ingredient in many household cleaning products. It is a mixture of unsaturated
hydrocarbons composed of terpenes, camphenes, and pinenes. The major components are
terpenes, which are found in plants and flowers. Wood distillates including pine oil and turpentine are
derived from pine trees. Patients who ingest pine oil often emit a strong pine odor. Wood distillates
are readily absorbed from the gastrointestinal tract, and ingestion may cause CNS and pulmonary
toxicity without aspiration.
The clinical features of pine oil ingestion can include CNS depression, respiratory failure, and
gastrointestinal dysfunction, which are rarely fatal.83,169 Aspiration pneumonitis remains the primary
clinical concern. Acute toxicity and management are similar to that of petroleum distillate ingestion.
Rare reported complications of wood distillate ingestion include turpentine-associated
thrombocytopenic purpura, AKI, and hemorrhagic cystitis.87,169
Lipoid Pneumonia
Ingestion of low-viscosity hydrocarbons poses risk of pulmonary aspiration with subsequent acute
pneumonitis. Conversely, viscous hydrocarbons rarely lead to pulmonary aspiration. Alternatively,
inhalation of aerosolized oil droplets can occur in various occupational settings, and exogenous
lipoid pneumonia may result. The most common xenobiotics involved are mineral or vegetable
oils.21,89,96
Initially, inhaled oil droplets are emulsified in the alveoli by surfactant, and then they are engulfed by
alveolar macrophages. Unfortunately, the macrophages are unable to readily process the
internalized, exogenous oil. Microscopically, persistent cytoplasmic droplets give a “foamy”
appearance to these “lipophages” that may persist for weeks to years. Not uncommonly, the initial
manifestations are limited or even subclinical, but once symptoms arise, illness may be prolonged
from months to years. Ultimately, irreversible proliferative fibrosis may develop.141
Silicone-based polymers share structural similarities and some physical properties with long-chain
hydrocarbons. Silicone polymers such as dimethicone exist as oily, viscous liquids at room
temperature are widely used as lubricants, antifoaming agents, and even as medicine and food
additives. Pulmonary aspiration or inhalation of aerosolized silicone droplets causes clinical
pneumonitis that is indistinguishable from that caused by their viscous hydrocarbon counterparts.
The time course of lung injury is similarly protracted, and complications may be expected.139
Tar and Asphalt Injury
Tar and asphalt injuries are common occupational hazards among construction workers. Asphalt
workers are at risk for toxic gas exposure of hydrogen sulfide, carbon monoxide, propane, methane,
and volatilized hydrocarbons.71 In addition, cutaneous exposure to these hot hydrocarbon mixtures
can cause severe burns. The material quickly hardens and is very difficult to remove. However,
immediate cooling with cold water is important to limit further thermal injury. Complete removal is
essential to ensure proper burn management and to limit infectious complications. Attempts to
remove hardened tar or asphalt mechanically often cause further damage. Dissolving the material
with mineral oil, petroleum jelly, or antibacterial ointments are met with variable success. Surfaceactive agents combined with an ointment (De-Solv-it, Tween-80, Polysorbate 80) are more
effective.41,149,160
DIAGNOSTIC TESTING
Laboratory and ancillary testing for hydrocarbon toxicity should be guided by available information
regarding the specific xenobiotic, the route of exposure, and the best attempt at quantifying the
exposure. Inhalation or ingestion of hydrocarbons associated with pulmonary aspiration is most likely
to result in pulmonary toxicity. The use of pulse oximetry, end-tidal CO2, and arterial blood gas
testing in this group of patients is warranted when clinically indicated. Early radiography is indicated
in patients who are severely symptomatic; however, radiographs performed immediately after
hydrocarbon ingestion have a poor predictive value for the occurrence of aspiration pneumonitis. In
the asymptomatic patient, early radiography is not cost effective. Patients observed for 6 hours after
an ingestion, who adequate oxygenation, are not tachypneic, demonstrate no abnormal pulmonary
findings, and have a normal chest radiograph obtained after the 6-hour observation period have a
good medical prognosis with very low risk of subsequent deterioration.8
The choice of specific diagnostic laboratory tests to assess organ system toxicity or function
following exposure to a hydrocarbon depends on the type, dose, and route of exposure, and on the
assessment of the patient’s clinical condition. Useful clinical tests may include pulse oximetry, endtidal CO2, and an ECG. Laboratory tests may include serum or urine electrolytes, venous or arterial
blood gas, complete blood counts, and creatine phosphokinase as clinically indicated. If a
hydrocarbon has specific target organ toxicities (eg, benzene/bone marrow, CCl4/liver, or nhexane/peripheral nervous system), evaluating and monitoring target organ system function is
indicated.
Specific diagnostic testing for hydrocarbon poisoning can include (a) bioassays for the specific
hydrocarbon or its metabolites in blood, breath, or urine, or (b) assessment of toxicity. Bioassays for
a hydrocarbon are seldom necessary for diagnosis or management of hydrocarbon poisoning in the
emergency setting and rarely clinically available. Exceptions might include testing to assist in
differential diagnosis (eg, testing for CCl4 in a comatose patient with unexplained hepatic and renal
toxicity or a carboxyhemoglobin determination in a paint stripper with chest pain), testing for worker
compensation purposes (eg, testing for urinary trichloroethanol and trichloroacetic acid in a worker
exposed to TCE with unexplained bouts of dizziness), or for forensic purposes (eg, sudden death in
a huffer).
Chronic overexposures to hydrocarbons, as occur with volatile substance use, can result in
persistent damage to the CNS. Damage can be detected and quantified using neuroimaging
methods such as MRI or positron emission tomography. Major MRI findings in patients with chronic
toluene abuse include atrophy, white matter T2 hyperintensity, and T2 hypointensity involving the
basal ganglia and thalamus.31 Neurobehavioral testing can be used to detect subtle central nervous
system effects following chronic occupational overexposures.
MANAGEMENT
Identification of the specific type, route, and amount of hydrocarbon exposure is rarely essential to
achieve effective management.
Decontamination is one of the cardinal principles of toxicology, with priority that is second only to
stabilization of the cardiopulmonary status. Safe decontamination can avoid further absorption and
also avoids secondary casualties in those attempting to provide care. Protection of rescuers with
appropriate personal protective equipment and rescue protocols is paramount, especially in
situations where the victim has lost consciousness. The principle of removing the patient from the
exposure (eg, vapor or gaseous hydrocarbon) or the exposure from the patient (eg, hydrocarbon
liquid on skin or clothing), while protecting the rescuer, implies that personal protective equipment be
considered at each level of the health care delivery system.
Exposed clothing should be removed and safely discarded as further absorption or inhalation of
hydrocarbons from grossly contaminated clothing can worsen systemic toxicity. Decontamination of
the skin should have a high priority in massive hydrocarbon exposures, particularly those exposures
involving highly toxic hydrocarbons. Water alone may be ineffective in decontaminating most
hydrocarbons, but early decontamination with soap and water may be adequate. The caregiver
should remain aware that certain hydrocarbons are highly flammable and pose a fire risk to hospital
staff (Chap. 131).
Several studies have attempted to evaluate the role of gastric decontamination after hydrocarbon
ingestion. Results were largely inconclusive and the level of evidence, poor. In the subset of patients
who were randomized to receive gastric lavage, 44% had pulmonary complications, compared with
47% of those who were not lavaged.121 Although available studies do not offer a conclusive answer to
the question of gastric emptying after hydrocarbon ingestion, the high incidence of spontaneous
emesis and the risk of aspiration essentially eliminate any consideration of gastric emptying in all but
the rarest of cases.
Activated charcoal (AC) has limited ability to decrease gastrointestinal absorption of hydrocarbons
and may distend the stomach and predispose patients to vomiting and aspiration.87,104 The use of AC
may be justified in patients with mixed overdoses, but its role in isolated hydrocarbon ingestions
appears very limited.
Antibiotics were once frequently administered in the setting of hydrocarbon pneumonitis to treat
possible bacterial superinfection,164 and they are still occasionally used today as fever and infiltrates
are common. Although animal models rapidly demonstrate superinfection, prophylactic antibiotics
only appear to alter pulmonary flora.28 Prophylactic antibiotics did not affect length of stay or
otherwise impact the outcome of 48 pediatric patients admitted for respiratory distress from
hydrocarbon poisoning.75 Similarly, in a randomized controlled study of pediatric patients suffering
from kerosene-induced pneumonitis, prophylactic amoxicillin did not affect signs or symptoms, the
rate of clinical deterioration (treatment failure), or duration of hospitalization.11 However, antibiotic
administration may be justified in severely poisoned patients. Ideally, sputum Gram stain or culture
results should direct antibiotic use.
Corticosteroids, like antibiotics, have been prophylactically administered in the setting of
hydrocarbon pulmonary toxicity.60,154 The rationale for their use is prevention and limitation of the
pulmonary inflammatory response after hydrocarbon injury. Animal models do not show any benefit
of corticosteroid administration5,143 and may increase the risk of bacterial superinfection. Furthermore,
a controlled human trial failed to show a benefit from corticosteroid administration.97 It is clear that
corticosteroid use does not improve the acute course of hydrocarbon pulmonary toxicity, although
some authors suggest improved outcome with delayed corticosteroid therapy there is little
supporting evidence.78,82 Coupled with the possible increased risk of bacterial superinfection,
corticosteroid administration in this setting is not recommended.
Patients with severe hydrocarbon toxicity pose unique problems for management. Respiratory
distress requiring mechanical ventilation in this setting may be associated with a large ventilation–
perfusion mismatch. The use of positive end-expiratory pressure (PEEP) in this setting is often
beneficial. However, very high levels of PEEP may be required, with subsequent increased risk of
barotrauma.131,179 High-frequency jet ventilation (HFJV), using very high respiratory rates (220–260)
with small tidal volumes, has helped to decrease the need for PEEP.30 Patients who continue to have
severe ventilation–perfusion mismatch despite PEEP and HFJV have benefited from extracorporeal
membrane oxygenation (ECMO).131,179 ECMO appears to be a useful option in severe pulmonary
toxicity after other treatments have failed. Early administration of surfactant may reduce pulmonary
toxicity, but experience under these circumstances is limited.98
Cyanosis is uncommon after hydrocarbon toxicity. Although this is most often caused by severe
hypoxia, methemoglobinemia associated with hydrocarbon exposure is reported.37,88 The potential for
methemoglobinemia should be investigated in patients who remain cyanotic following normalization
of arterial oxygen tension (Chap. 127).
Hypotension in severe hydrocarbon toxicity raises additional concerns. The etiology of hypotension
in this setting is often compromise of cardiac output because of high levels of PEEP. Hydrocarbons
do not have significant direct cardiovascular effects, and decreasing the PEEP may improve
hemodynamics. The use of β-adrenergic agonists such as dopamine, epinephrine, isoproterenol,
and norepinephrine should be avoided if possible, as certain hydrocarbons predispose to
dysrhythmias.13,110,126
Management of dysrhythmias associated with hydrocarbon toxicity should include consideration of
electrolyte and acid–base abnormalities such as hypokalemia and acidosis result from toluene,
hypoxemia, hypotension, and hypothermia. Ventricular fibrillation poses a specific concern, as
common resuscitation algorithms recommendepinephrine administration to treat this rhythm. If it is
ascertained that the dysrhythmia emanates from myocardial sensitization by a hydrocarbon solvent,
catecholamines should be avoided. In this setting, lidocaine has been used successfully, as have βadrenergic antagonists.105
Hyperbaric oxygen (HBO) was studied in a rat model of severe kerosene-induced
pneumonitis.134 HBO at 4 ATA showed some benefit in 24-hour survival rates. No follow-up studies
have been performed. Patients with CCl4 poisoning, however, may benefit from hyperbaric
oxygen27,158 (Antidotes in Depth: A37).
In the past, hospital admission was routinely recommended for patients who ingested hydrocarbons,
because of concern over possible delayed symptom onset and progression of toxicity. Several
reports documented patients with relatively asymptomatic presentations who rapidly decompensated
with respiratory compromise. However, progressive symptoms after hydrocarbon ingestion are
rare,8,94 and these recommendations predate noninvasive assessments of gas exchange. In a
retrospective study of 950 patients, only 14 (1.5%) had progression of pulmonary toxicity.8 Of these
14, seven had persistence of symptoms for less than 24 hours. Eight hundred patients were
asymptomatic on initial evaluation with normal chest radiographs, remained asymptomatic after 6 to
8 hours of observation, and had a normal repeat radiograph. No patient in this group of 800 had
progressive symptoms, and all were discharged without clinical deterioration. Seventy-one of the
950 patients had initial respiratory symptoms but were asymptomatic at initial medical evaluation. Of
the 71 patients, 36 had radiographic evidence of pneumonitis. Of these 36 patients, two (6%)
developed progression of pulmonary symptoms during the 6-hour observation period. Of the 35 who
had a normal radiograph, two (6%) developed pulmonary symptoms and radiographic pneumonitis
during the 6-hour observation period. The four patients who were hospitalized for progression of
symptoms became asymptomatic over the next 24 hours and had no complications.
A separate poison center–based study evaluated 120 asymptomatic patients over an 18-hour
telephone follow-up period.94 Sixty-two patients had initial pulmonary symptoms that quickly resolved.
One of the 62 patients (1.6%) developed progressive pulmonary toxicity. This patient was
hospitalized and had resolution of symptoms within 24 hours without complications.
A number of investigators have suggested protocols for determining which patients can be safely
discharged.8,81,94 None of these protocols has been prospectively validated. However, rational
guidelines for hospitalization can be recommended. Those patients who have clinical evidence of
toxicity, and most individuals with intentional ingestions, should be hospitalized. Patients who do not
have any initial symptoms, have normal chest radiographs obtained at least 6 hours after ingestion,
and who do not develop symptoms during the 6-hour observation period can be safely discharged.
Care should be individualized for patients who are asymptomatic but who have radiographic
evidence of hydrocarbon pneumonitis and for patients who have initial respiratory symptoms but
quickly become asymptomatic during medical evaluation. Reliable patients may be considered for
possible discharge with next-day follow-up.
SUMMARY

Hydrocarbons are a diverse group of xenobiotics that can cause toxicity by inhalation,
ingestion, or dermal absorption.

Populations at particular risk for toxicity include children who ingest hydrocarbon compounds,
workers who are occupationally exposed by inhalation or dermal absorption, and youths who
intentionally inhale volatile hydrocarbons.

Aspiration pneumonitis is the primary concern after hydrocarbon ingestion, with the risk of
aspiration dependent on many factors including viscosity, volatility, surface tension, amount
ingested, and the presence of emesis.

Many hydrocarbons are poorly absorbed from the gastrointestinal tract and unlikely to
produce systemic poisoning. Acute systemic toxicity is unlikely to occur in the absence of
CNS effects such as excitation or sedation.

An exposed child who is asymptomatic after 6 hours of observation and who has a normal
chest radiograph taken after 6 hours of observation is most likely safe for discharge.
References
1.
Abu-Ekteish F: Kerosene poisoning in children: a report from northern Jordan. Trop
Doct. 2002;32:27–29. [PubMed: 11991021]
2.
Adler R, Robinson RG, Bindin J: Intravascular hemolysis: an unusual complication of hydrocarbon
ingestion. J Pediatr. 1976;89:679–680. [PubMed: 957020]
3.
Ahmed AE, Kubic VL, Stevens JL, Anders MW: Halogenated methanes: metabolism and
toxicity. Fed Proc. 1980;39:3150–3155. [PubMed: 6775982]
4.
Aksoy M, Erdem S, Dincol G et al.: Aplastic anemia due to chemicals and drugs: a study of 108
patients. Sex Transm Dis. 1984;11:347–350. [PubMed: 6523315]
5.
Albert WC, Inkley SR: The efficacy of steroid therapy in the treatment of experimental kerosene
pneumonitis. Am Rev Respir Dis. 1968;98:888–889. [PubMed: 5683485]
6.
Algren JT, Rodgers GC: Intravascular hemolysis associated with hydrocarbon poisoning. Pediatr
Emerg Care. 1992;8:34–35. [PubMed: 1603687]
7.
Altenkirch H, Stoltenburg G, Wagner HM: Experimental studies on hydrocarbon neuropathies
induced by methyl-ethyl-ketone (MEK). J Neurol. 1978;219:159–170. [PubMed: 84859]
8.
Anas N, Namasonthi V, Ginsburg CM: Criteria for hospitalizing children who have ingested
products containing hydrocarbons. JAMA. 1981;246:840–843. [PubMed: 7253158]
[JAMA and JAMA Network Journals Full Text]
9.
Ashford NA: New scientific evidence and public health imperatives. N Engl J Med.1987;316:1084–
1085. [PubMed: 3561461]
10.
Baldachin BJ, Melmed RN: Clinical and Therapeutic Aspects of Kerosene Poisoning: A Series of
200 Cases. Br Med J. 1964;2:28–30. [PubMed: 14147771]
11.
Balme KH, Zar HJ, Mann MD: A randomised controlled study on the efficacy of prophylactic
antibiotics in the management of kerosene-associated pneumonitis at a tertiary children’s hospital in
South Africa. Clin Toxicol. 2013;51:335.
12.
Ban M, Hettich D, Bonnet P: Effect of inhaled industrial chemicals on systemic and local immune
response. Toxicology. 2003;184:41–50. [PubMed: 12505375]
13.
Bass M: Death from sniffing gasoline. N Engl J Med. 1978;299:203–203. [PubMed: 661902]
14.
Bass M: Sudden sniffing death. JAMA. 1970;212:2075–2079. [PubMed: 5467774]
[JAMA and JAMA Network Journals Full Text]
15.
Batlle DC, Sabatini S, Kurtzman NA: On the mechanism of toluene-induced renal tubular
acidosis. Nephron. 1988;49:210–218. [PubMed: 3135502]
16.
Beamon RF, Siegel CJ, Landers G, Green V: Hydrocarbon ingestion in children: a six-year
retrospective study. JACEP. 1976;5:771–775. [PubMed: 1018351]
17.
Beckstead MJ, Weiner JL, Eger EI et al.: Glycine and gamma-aminobutyric acid(A) receptor
function is enhanced by inhaled drugs of abuse. Mol Pharmacol.2000;57:1199–1205. [PubMed:
10825391]
18.
Belonwu RO, Adeleke SI: A seven-year review of accidental kerosene poisoning in children at
Aminu Kano Teaching Hospital, Kano. Niger J Med. 2008;17:380–382. [PubMed: 19048749]
19.
Benois A, Petitjeans F, Raynaud L et al.: Clinical and therapeutic aspects of childhood kerosene
poisoning in Djibouti. Trop Doct. 2009;39:236–238. [PubMed: 19762580]
20.
Bergeson PS, Hales SW, Lustgarten MD, Lipow HW: Pneumatoceles following hydrocarbon
ingestion. Report of three cases and review of the literature. Am J Dis Child. 1975;129:49–
54. [PubMed: 1130343]
21.
Betancourt SL, Martinez-Jimenez S, Rossi SE et al.: Lipoid pneumonia: spectrum of clinical and
radiologic manifestations. AJR Am J Roentgenol. 2010;194:103–109.
CrossRef [PubMed: 20028911]
22.
Blattner RJ, Collins VP, Daeschner CW, Jr.: Hydrocarbon pneumonitis. Pediatr Clin North
Am. 1957:243–253.
23.
Bleecker ML, Bolla KI, Agnew J et al.: Dose-related subclinical neurobehavioral effects of chronic
exposure to low levels of organic solvents. Am J Ind Med.1991;19:715–728.
CrossRef [PubMed: 1652894]
24.
Bombassei GJ, Kaplan AA: The association between hydrocarbon exposure and anti-glomerular
basement membrane antibody-mediated disease (Goodpasture’s syndrome). Am J Ind
Med. 1992;21:141–153.
CrossRef [PubMed: 1536151]
25.
Bos PM, de Mik G, Bragt PC: Critical review of the toxicity of methyl n-butyl ketone: risk from
occupational exposure. Am J Ind Med. 1991;20:175–194.
CrossRef [PubMed: 1659188]
26.
Bratton L, Haddow JE: Ingestion of charcoal lighter fluid. J Pediatr. 1975;87:633–636.
CrossRef [PubMed: 1159594]
27.
Brent JA, Rumack BH: Role of free radicals in toxic hepatic injury. II. Are free radicals the cause of
toxin-induced liver injury? J Toxicol Clin Toxicol. 1993;31:173–196.
CrossRef [PubMed: 8433412]
28.
Brown J, Burke B, Dajani AS: Experimental kerosene pneumonia: evaluation of some therapeutic
regimens. J Pediatr. 1974;84:396–341.
CrossRef [PubMed: 4149566]
29.
Burkhart KK, Hall AH, Gerace R, Rumack BH: Hyperbaric oxygen treatment for carbon
tetrachloride poisoning. Drug Saf. 1991;6:332–338.
CrossRef [PubMed: 1930739]
30.
Bysani GK, Rucoba RJ, Noah ZL: Treatment of hydrocarbon pneumonitis. High frequency jet
ventilation as an alternative to extracorporeal membrane oxygenation.Chest. 1994;106:300–303.
CrossRef [PubMed: 8020296]
31.
Caldemeyer KS, Armstrong SW, George KK et al.: The spectrum of neuroimaging abnormalities in
solvent abuse and their clinical correlation. J Neuroimaging.1996;6:167–173. [PubMed: 8704292]
32.
Cantor RS: The lateral pressure profile in membranes: a physical mechanism of general
anesthesia. Biochemistry. 1997;36:2339–2344.
CrossRef [PubMed: 9054538]
33.
Carlisle EJ, Donnelly SM, Vasuvattakul S et al.: Glue-sniffing and distal renal tubular acidosis:
sticking to the facts. J Am Soc Nephrol. 1991;1:1019–1027. [PubMed: 1912400]
34.
Cavanagh JB, Buxton PH: Trichloroethylene cranial neuropathy: is it really a toxic neuropathy or
does it activate latent herpes virus? J Neurol Neurosurg Psychiatry.1989;52:297–303.
CrossRef [PubMed: 2538571]
35.
Centers for Disease Control and Prevention: n-Hexane-related peripheral neuropathy among
automotive technicians—California, 1999-2000. MMWR Morb Mortal Wkly Rep. 2001;50:1011–
1013. [PubMed: 11724159]
36.
Chang YC: Neurotoxic effects of n-hexane on the human central nervous system: evoked potential
abnormalities in n-hexane polyneuropathy. J Neurol Neurosurg Psychiatry. 1987;50:269–274.
CrossRef [PubMed: 3031221]
37.
Curry S: Methemoglobinemia. Ann Emerg Med. 1982;11:214–221.
CrossRef [PubMed: 7073040]
38.
Daffner RH, Jimenez JP: The double gastric fluid level in kerosene
poisoning.Radiology. 1973;106:383–384.
CrossRef [PubMed: 4684480]
39.
Das M, Misra MP: Acne and folliculitis due to diesel oil. Contact Dermatitis.1988;18:120–121.
CrossRef [PubMed: 2966703]
40.
Decoufle P, Blattner WA, Blair A: Mortality among chemical workers exposed to benzene and
other agents. Environ Res. 1983;30:16–25.
CrossRef [PubMed: 6832104]
41.
Demling RH, Buerstatte WR, Perea A: Management of hot tar burns. J Trauma.1980;20:242–242.
CrossRef [PubMed: 7359599]
42.
Dildy-Mayfield JE, Eger EI, Harris RA: Anesthetics produce subunit-selective actions on glutamate
receptors. J Pharmacol Exp Ther. 1996;276:1058–1065. [PubMed: 8786535]
43.
Dilger JP: The effects of general anaesthetics on ligand-gated ion channels. Br J
Anaesth. 2002;89:41–51.
CrossRef [PubMed: 12173240]
44.
Eade NR, Taussig LM, Marks MI: Hydrocarbon pneumonitis. Pediatrics.1974;54:351–
357. [PubMed: 4606628]
45.
Eskandarlou M, Moaddab AH: Chest wall necrosis and empyema resulting from attempting suicide
by injection of petroleum into the pleural cavity. Emerg Med J.2010;27:616–618.
CrossRef [PubMed: 20558490]
46.
Fagbule DO, Joiner KT: Kerosene poisoning in childhood: a 6-year prospective study at the
University of Ilorin Teaching Hospital. West Afr J Med. 1992;11:116–121. [PubMed: 1390371]
47.
Feldman RG, Chirico-Post J, Proctor SP: Blink reflex latency after exposure to trichloroethylene in
well water. Arch Environ Health. 1988;43:143–148.
CrossRef [PubMed: 3377549]
48.
Feldman RG, White RF, Currie JN et al.: Long-term follow-up after single toxic exposure to
trichloroethylene. Am J Ind Med. 1985;8:119–126.
CrossRef [PubMed: 4050794]
49.
Fialkov JA, Freiberg A: High pressure injection injuries: an overview. J Emerg Med.1991;9:367–
371.
CrossRef [PubMed: 1940241]
50.
Filley CM: Toluene abuse and white matter: a model of toxic leukoencephalopathy.Psychiatr Clin
North Am. 2013;36:293–302.
CrossRef [PubMed: 23688693]
51.
Filley CM: Toxic leukoencephalopathy: In: The Behavioral Neurology of White Matter.2nd ed. New
York: Oxford University Press; 2013:163–185.
52.
Filley CM, Halliday W, Kleinschmidt-DeMasters BK: The effects of toluene on the central nervous
system. J Neuropathol Exp Neurol. 2004;63:1–12. [PubMed: 14748556]
53.
Filley CM, Heaton RK, Rosenberg NL: White matter dementia in chronic toluene
abuse. Neurology. 1990;40:532–534.
CrossRef [PubMed: 2314597]
54.
Foley JC, Dreyer NB, Soule AB, Woll E: Kerosene poisoning in young
children.Radiology. 1954;62:817–829.
CrossRef [PubMed: 13167415]
55.
Gargas ML, Burgess RJ, Voisard DE et al.: Partition coefficients of low-molecular-weight volatile
chemicals in various liquids and tissues. Toxicol Appl Pharmacol.1989;98:87–99.
CrossRef [PubMed: 2929023]
56.
Gash DM, Rutland K, Hudson NL et al.: Trichloroethylene: parkinsonism and complex 1
mitochondrial neurotoxicity. Ann Neurol. 2008;63:184–192.
CrossRef [PubMed: 18157908]
57.
Gerarde HW: Toxicologiccal studies on hydrocarbons. IX. The aspiration hazard and toxicity of
hydrocarbons and hydrocarbon mixtures. Arch Environ Health. 1963;6:329–341.
CrossRef [PubMed: 13947290]
58.
Gershon-Cohen J, Bringhurst LS, Byrne RN: Roentgenography of kerosene poisoning, chemical
pneumonitis. Am J Roentgenol Radium Ther Nucl Med.1953;69:557–562. [PubMed: 13030911]
59.
Graham DG: Neurotoxicants and the cytoskeleton. Curr Opin Neurol. 1999;12:733–737.
CrossRef [PubMed: 10676757]
60.
Graham JR: Pneumonitis following aspiration of crude oil and its treatment by steroid
hormones. Trans Am Clin Climatol Assoc. 1955;67:104–112. [PubMed: 13360841]
61.
Gross P, McNerney JM, Babyak MA: Kerosene pnuemonits: an experimental study with small
doses. Am Rev Respir Dis. 1963;88:656–663. [PubMed: 14082679]
62.
Gross SA, Avens HJ, Banducci AM et al.: Analysis of BTEX groundwater concentrations from
surface spills associated with hydraulic fracturing operations. J Air Waste Manag
Assoc. 2013;63:424–432.
CrossRef [PubMed: 23687727]
63.
Gupta P, Singh RP, Murali MV et al.: Kerosene oil poisoning—a childhood menace.Indian
Pediatr. 1992;29:979–984. [PubMed: 1459719]
64.
Gurwitz D, Kattan M, Levison H, Culham JA: Pulmonary function abnormalities in asymptomatic
children after hydrocarbon pneumonitis. Pediatrics. 1978;62:789–794. [PubMed: 724322]
65.
Hake CL, Stewart RD: Human exposure to tetrachloroethylene: inhalation and skin contact. Environ
Health Perspect. 1977;21:231–238.
CrossRef [PubMed: 612448]
66.
Halsey MJ: Physical chemistry applied to anaesthetic action. Br J Anaesth.1974;46:172–180.
CrossRef [PubMed: 4604910]
67.
Hansbrough JF, Zapata-Sirvent R, Dominic W et al.: Hydrocarbon contact injuries. J
Trauma. 1985;25:250–252.
CrossRef [PubMed: 3981678]
68.
Hemmings HC, Yan W, Westphalen RI, Ryan TA: The general anesthetic isoflurane depresses
synaptic vesicle exocytosis. Mol Pharmacol. 2005;67:1591–1599.
CrossRef [PubMed: 15728262]
69.
Herskowitz A, Ishii N, Schaumburg H: N-hexane neuropathy. A syndrome occurring as a result of
industrial exposure. N Engl J Med. 1971;285:82–85.
CrossRef [PubMed: 4326704]
70.
Himmel HM: Mechanisms involved in cardiac sensitization by volatile anesthetics: general
applicability to halogenated hydrocarbons? Crit Rev Toxicol. 2008;38:773–803.
CrossRef [PubMed: 18941968]
71.
Hoidal CR, Hall AH, Robinson MD et al.: Hydrogen sulfide poisoning from toxic inhalations of
roofing asphalt fumes. Ann Emerg Med. 1986;15:826–830.
CrossRef [PubMed: 3729106]
72.
James FW, Kaplan S, Benzing G 3rd: Cardiac complications following hydrocarbon ingestion. Am
J Dis Child. 1971;121:431–433. [PubMed: 5091538]
73.
Janssen S, van der Geest S, Meijer S, Uges DR: Impairment of organ function after oral ingestion
of refined petrol. Intensive Care Med. 1988;14:238–240.
CrossRef [PubMed: 3379185]
74.
Javier Perez A, Courel M, Sobrado J, Gonzalez L: Acute renal failure after topical application of
carbon tetrachloride. Lancet. 1987;1:515–516.
CrossRef [PubMed: 2881079]
75.
Jayashree M, Singhi S, Gupta A: Predictors of outcome in children with hydrocarbon poisoning
receiving intensive care. Indian Pediatr. 2006;43:715–719. [PubMed: 16951435]
76.
Jiao Z, De Jesus VR, Iravanian S et al.: A possible mechanism of halocarbon-induced cardiac
sensitization arrhythmias. J Mol Cell Cardiol. 2006;41:698–705.
CrossRef [PubMed: 16919292]
77.
Joron GE, Cameron DG, Halpenny GW: Massive necrosis of the liver due to trichlorethylene. Can
Med Assoc J. 1955;73:890–891. [PubMed: 13270193]
78.
Kamijo Y, Soma K, Asari Y, Ohwada T: Pulse steroid therapy in adult respiratory distress
syndrome following petroleum naphtha ingestion. J Toxicol Clin Toxicol.2000;38:59–62.
CrossRef [PubMed: 10696927]
79.
Kao KC, Tsai YH, Lin MC et al.: Hypokalemic muscular paralysis causing acute respiratory failure
due to rhabdomyolysis with renal tubular acidosis in a chronic glue sniffer. J Toxicol Clin
Toxicol. 2000;38:679–681.
CrossRef [PubMed: 11185978]
80.
King PJ, Morris JG, Pollard JD: Glue sniffing neuropathy. Aust N Z J Med.1985;15:293–299.
CrossRef [PubMed: 2998315]
81.
Klein BL, Simon JE: Hydrocarbon poisonings. Pediatr Clin North Am. 1986;33:411–419. [PubMed:
2870464]
82.
Kollef MH, Schuster DP: The acute respiratory distress syndrome. N Engl J Med.1995;332:27–37.
CrossRef [PubMed: 7646623]
83.
Koppel C, Tenczer J, Tonnesmann U et al.: Acute poisoning with pine oil—metabolism of
monoterpenes. Arch Toxicol. 1981;49:73–78.
CrossRef [PubMed: 7325802]
84.
Kornfeld M, Moser AB, Moser HW et al.: Solvent vapor abuse leukoencephalopathy. Comparison
to adrenoleukodystrophy. J Neuropathol Exp Neurol. 1994;53:389–398.
CrossRef [PubMed: 8021713]
85.
Krasowski MD, Harrison NL: General anaesthetic actions on ligand-gated ion channels. Cell Mol
Life Sci. 1999;55:1278–1303.
CrossRef [PubMed: 10487207]
86.
Kwong YL, Chan TK: Toxic occupational exposures and paroxysmal nocturnal
haemoglobinuria. Lancet. 1993;341:443–443.
CrossRef [PubMed: 8094213]
87.
Laass W: Therapy of acute oral poisoning by organic solvents: treatment by activated charcoal in
combination with laxatives. Arch Toxicol Suppl. 1980;4:406–409. [PubMed: 6933949]
88.
Lareng L, Bierme R, Jorda MF et al.: [Acute, toxic methemoglobinemia from accidental ingestion
of nitrobenzene]. Eur J Toxicol Environ Hyg. 1974;7:12–16. [PubMed: 4844306]
89.
Lauque D, Dongay G, Levade T et al.: Bronchoalveolar lavage in liquid paraffin
pneumonitis. Chest. 1990;98:1149–1155.
CrossRef [PubMed: 1699708]
90.
Leandri M, Schizzi R, Scielzo C, Favale E: Electrophysiological evidence of trigeminal root
damage after trichloroethylene exposure. Muscle Nerve. 1995;18:467–468.
CrossRef [PubMed: 7715634]
91.
Liao JT, Oehme FW: Literature reviews of phenolic compounds, IV, o-Phenylphenol.Vet Hum
Toxicol. 1980;22:406–408. [PubMed: 7210470]
92.
Lifshitz M, Sofer S, Gorodischer R: Hydrocarbon poisoning in children: a 5-year retrospective
study. Wilderness Environ Med. 2003;14:78–82.
CrossRef [PubMed: 12825880]
93.
Lucas GN: Kerosene oil poisoning in children: a hospital-based prospective study in Sri
Lanka. Indian J Pediatr. 1994;61:683–687.
CrossRef [PubMed: 7721373]
94.
Machado B, Cross K, Snodgrass WR: Accidental hydrocarbon ingestion cases telephoned to a
regional poison center. Ann Emerg Med. 1988;17:804–807.
CrossRef [PubMed: 3394983]
95.
Mann MD, Pirie DJ, Wolfsdorf J: Kerosene absorption in primates. J Pediatr.1977;91:495–498.
CrossRef [PubMed: 408472]
96.
Marchiori E, Zanetti G, Mano CM, Hochhegger B: Exogenous lipoid pneumonia. Clinical and
radiological manifestations. Respir Med. 2011;105:659–666.
CrossRef [PubMed: 21185165]
97.
Marks MI, Chicoine L, Legere G, Hillman E: Adrenocorticosteroid treatment of hydrocarbon
pneumonia in children—a cooperative study. J Pediatr. 1972;81:366–369.
CrossRef [PubMed: 4557603]
98.
Mastropietro CW, Valentine K: Early administration of intratracheal surfactant (calfactant) after
hydrocarbon aspiration. Pediatrics. 2011;127:1600–1604.
CrossRef
99.
McKenzie LM, Witter RZ, Newman LS, Adgate JL: Human health risk assessment of air emissions
from development of unconventional natural gas resources. Sci Total Environ. 2012;424:79–87.
CrossRef [PubMed: 22444058]
100.
McNally WD: Kerosene poisoning in children; a study of 48 cases. J Med Assoc State
Ala. 1957;27:53–55. [PubMed: 13463515]
101.
Mehlman MA: Benzene health effects: unanswered questions still not addressed.Am J Ind
Med. 1991;20:707–711.
CrossRef [PubMed: 1793112]
102.
Meredith TJ, Ruprah M, Liddle A, Flanagan RJ: Diagnosis and treatment of acute poisoning with
volatile substances. Hum Toxicol. 1989;8:277–286.
CrossRef [PubMed: 2777267]
103.
Montgomery CT, Smith MB: Hydraulic fracturing. History of an enduring technology. JPT Online
(Society of Petroleum Engineers).http://www.spe.org/jpt/print/archives/2010/12/10Hydraulic.pdf.
Accessed June 12, 2013.
104.
Morgan DP, Dotson TB, Lin LI: Effectiveness of activated charcoal, mineral oil, andcastor oil in
limiting gastrointestinal absorption of a chlorinated hydrocarbon pesticide. Clin Toxicol. 1977;11:61–
70.
CrossRef [PubMed: 68845]
105.
Mortiz F, de La Chapelle A, Bauer F et al.: Esmolol in the treatment of severe arrhythmia after
acute trichloroethylene poisoning. Intensive Care Med. 2000;26:256.
CrossRef [PubMed: 10784325]
106.
Moss AH, Gabow PA, Kaehny WD et al.: Fanconi’s syndrome and distal renal tubular acidosis
after glue sniffing. Ann Intern Med. 1980;92:69–70.
CrossRef [PubMed: 7350875]
107.
Mrvos R, Dean BS, Krenzelok EP: High pressure injection injuries: a serious occupational
hazard. J Toxicol Clin Toxicol. 1987;25:297–304.
CrossRef [PubMed: 3669115]
108.
Nagano K, Sasaki T, Umeda Y et al.: Inhalation carcinogenicity and chronic toxicity of carbon
tetrachloride in rats and mice. Inhal Toxicol. 2007;19:1089–1103.
CrossRef [PubMed: 17957549]
109.
Nagi NA, Abdulallah ZA: Kerosene poisoning in children in Iraq. Postgrad Med J.1995;71:419–422.
CrossRef [PubMed: 7567734]
110.
Nelson LS: Toxicologic myocardial sensitization. J Toxicol Clin Toxicol. 2002;40:867–879.
CrossRef [PubMed: 12507056]
111.
Nierenberg DW, Horowitz MB, Harris KM, James DH: Mineral spirits inhalation associated with
hemolysis, pulmonary edema, and ventricular fibrillation. Arch Intern Med. 1991;151:1437–1440.
CrossRef [PubMed: 2064497]
[Archives of Internal Medicine Full Text]
112.
Norman WC: Trichloroethylene as human carcinogen. Toxicology. 2005;208:171–172.
CrossRef [PubMed: 15664443]
113.
Nouri L, al-Rahim K: Kerosene poisoning in children. Postgrad Med J. 1970;46:71–75.
CrossRef [PubMed: 5416507]
114.
Okuda M, Kunitsugu I, Kobayakawa S, Hobara T: Inhibitory effect of 1,1,1-trichloroethane on
calcium channels of neurons. J Toxicol Sci. 2001;26:169–176.
CrossRef [PubMed: 11552300]
115.
Olstad RB, Lord RM Jr: Kerosene intoxication. AMA Am J Dis Child. 1952;83:446–453. [PubMed:
14902097]
116.
Ott MG, Skory LK, Holder BB et al.: Health evaluation of employees occupationally exposed to
methylene chloride. Scand J Work Environ Health. 1983;9(suppl 1):1–38.
CrossRef [PubMed: 6857191]
117.
Ouyang W, Herold KF, Hemmings HC: Comparative effects of halogenated inhaled anesthetics on
voltage-gated Na+ channel function. Anesthesiology. 2009;110:582–590.
CrossRef [PubMed: 19225394]
118.
Page NN: Assessment of trichloroethylene as an occupational carcinogen. IARC Sci Publ. 1979:75–
79.
119.
Paustenbach DJ, Bass RD, Price P: Benzene toxicity and risk assessment, 1972–1992:
implications for future regulation. Environ Health Perspect. 1993;101 (suppl 6):177–200.
CrossRef [PubMed: 8020442]
120.
Pierce CH, Dills RL, Silvey GW, Kalman DA: Partition coefficients between human blood or
adipose tissue and air for aromatic solvents. Scand J Work Environ Health.1996;22:112–118.
CrossRef [PubMed: 8738889]
121.
Press E, Adams WC, Chittenden RF: Cooperative kerosene poisoning study: evaluation of gastric
lavage and other factors in the treatment of accidental ingestion of petroleum distillate
products. Pediatrics. 1962;29:648–674.
122.
Prockop L: Neurotoxic volatile substances. Neurology. 1979;29:862–865.
CrossRef [PubMed: 572008]
123.
Raphael M, Nadiras P, Flacke-Vordos N: Acute methylene chloride intoxication—a case report on
domestic poisoning. Eur J Emerg Med. 2002;9:57–59.
CrossRef [PubMed: 11989499]
124.
Reed E, Leikin S, Kerman H: Kerosene intoxication. Am J Dis Child. 1950;15:623–632.
125.
Reed RP, Conradie FM: The epidemiology and clinical features of paraffin (kerosene) poisoning in
rural African children. Ann Trop Paediatr. 1997;17:49–55. [PubMed: 9176578]
126.
Reinhardt CF, Mullin LS, Maxfield ME: Epinephrine-induced cardiac arrhythmia potential of some
common industrial solvents. J Occup Med. 1973;15:953–955. [PubMed: 4763670]
127.
Richardson JA, Pratt-Thomas HR: Toxic effects of varying doses of kerosene administered by
different routes. Am J Med Sci. 1951;221:531–536.
CrossRef [PubMed: 14829453]
128.
Rinsky RA, Smith AB, Hornung R et al.: Benzene and leukemia. An epidemiologic risk
assessment. N Engl J Med. 1987;316:1044–1050.
CrossRef [PubMed: 3561457]
129.
Rush MD, Schoenfeld CN, Watson WA: Skin necrosis and venous thrombosis from subcutaneous
injection of charcoal lighter fluid (naptha). Am J Emerg Med.1998;16:508–511.
CrossRef [PubMed: 9725968]
130.
Saida K, Mendell JR, Weiss HS: Peripheral nerve changes induced by methyl n-butyl ketone and
potentiation by methyl ethyl ketone. J Neuropathol Exp Neurol.1976;35:207–225.
CrossRef [PubMed: 178832]
131.
Scalzo AJ, Weber TR, Jaeger RW et al.: Extracorporeal membrane oxygenation for hydrocarbon
aspiration. Am J Dis Child. 1990;144:867–871. [PubMed: 2378332]
132.
Schaumburg HH: Toluene. In: Spencer PS, Schaumburg HH, Ludolph AC, eds:Experimental and
Clinical Neurotoxicology. 2nd ed. New York: Oxford University Press; 2000:1183–1189.
133.
Scholz EP, Alter M, Zitron E et al.: In vitro modulation of HERG channels by organochlorine
solvent trichlormethane as potential explanation for proarrhythmic effects of chloroform. Toxicol
Lett. 2006;165:156–166.
CrossRef [PubMed: 16647228]
134.
Schwartz SI, Breslau RC, Kutner F, Smith D: Effects of drugs and hyperbaric oxygen environment
on experimental kerosene pneumonitis. Dis Chest.1965;47:353–359.
CrossRef [PubMed: 14272534]
135.
Shafer TJ, Bushnell PJ, Benignus VA, Woodward JJ: Perturbation of voltage-sensitive Ca2+
channel function by volatile organic solvents. J Pharmacol Exp Ther.2005;315:1109–1118.
CrossRef [PubMed: 16109744]
136.
Shin W-J, Winegar BD: Modulation of noninactivating K+ channels in rat cerebellar granule neurons
by halothane, isoflurane, and sevoflurane. Anesth Analg.2003;96:1340–1344.
CrossRef [PubMed: 12707130]
137.
Shotar AM: Kerosene poisoning in childhood: a 6-year prospective study at the Princess Rahmat
Teaching Hospital. Neuro Endocrinol Lett. 2005;26:835–838. [PubMed: 16380681]
138.
Sikkema J, de Bont JA, Poolman B: Mechanisms of membrane toxicity of hydrocarbons. Microbiol
Rev. 1995;59:201–222. [PubMed: 7603409]
139.
Silicone Environmental Health and Safety Council of North America: Guidance for aerosol
applications of silicone-based materials
(2001).http://www.sehsc.com/PDFs/Guidance%20for%20Aerosol%20Applications-Sep%2001.pdf.
Accessed June 12, 2013.
140.
Smith AG, Albers JW: n-Hexane neuropathy due to rubber cement sniffing. Muscle
Nerve. 1997;20:1445–1450.
CrossRef [PubMed: 9342162]
141.
Spickard A, Hirschmann JV: Exogenous lipoid pneumonia. Arch Intern Med.1994;154:686–692.
CrossRef [PubMed: 8129503]
[Archives of Internal Medicine Full Text]
142.
Stadnicka A, Kwok WM, Hartmann HA, Bosnjak ZJ: Effects of halothane and isoflurane on fast
and slow inactivation of human heart hH1a sodium channels.Anesthesiology. 1999;90:1671–1683.
CrossRef [PubMed: 10360866]
143.
Steele RW, Conklin RH, Mark HM: Corticosteroids and antibiotics for the treatment of fulminant
hydrocarbon aspiration. JAMA. 1972;219:1434–1437.
CrossRef [PubMed: 5066898]
[JAMA and JAMA Network Journals Full Text]
144.
Steiner MM: Syndromes of kerosene poisoning in children. Am J Dis Child.1947;74:32–
44. [PubMed: 20258318]
145.
Stevenson A, Yaqoob M, Mason H et al.: Biochemical markers of basement membrane
disturbances and occupational exposure to hydrocarbons and mixed solvents. QJM. 1995;88:23–
28. [PubMed: 7534597]
146.
Stewart BW: Trichloroethylene and cancer: a carcinogen on trial. Med J Aust.2001;174:244–
247. [PubMed: 11280697]
147.
Stewart RD, Hake CL, Peterson JE: “Degreaser’s flush”. Arch Environ Health.1974;29:1–5.
CrossRef [PubMed: 4276444]
148.
Stockman JA: More on hydrocarbon-induced hemolysis. J Pediatr. 1977;90:848–848.
CrossRef [PubMed: 853349]
149.
Stratta RJ, Saffle JR, Kravitz M, Warden GD: Management of tar and asphalt injuries. Am J
Surg. 1983;146:766–769.
CrossRef [PubMed: 6650759]
150.
Streicher HZ, Gabow PA, Moss AH et al.: Syndromes of toluene sniffing in adults.Ann Intern
Med. 1981;94:758–762.
CrossRef [PubMed: 7235417]
151.
Szlatenyi CS, Wang RY: Encephalopathy and cranial nerve palsies caused by intentional
trichloroethylene inhalation. Am J Emerg Med. 1996;14:464–466.
CrossRef [PubMed: 8765111]
152.
Takeuchi Y, Ono Y, Hisanaga N et al.: A comparative study on the neurotoxicity of n-pentane, nhexane, and n-heptane in the rat. Br J Ind Med. 1980;37:241–247. [PubMed: 7426474]
153.
Tang HL, Chu KH, Cheuk A et al.: Renal tubular acidosis and severe hypophosphataemia due to
toluene inhalation. Hong Kong Med J. 2005;11:50–53. [PubMed: 15687517]
154.
Taussig LM, Castro O, Landau LI, Beaudry PH: Pulmonary function 8 to 10 years after
hydrocarbon pneumonitis. Normal findings in three children carefully studied.Clin Pediatr
(Phila). 1977;16:57–59.
CrossRef [PubMed: 830460]
155.
Tomenson JA, Baron CE, O’Sullivan JJ et al.: Hepatic function in workers occupationally exposed
to carbon tetrachloride. Occup Environ Med. 1995;52:508–514.
CrossRef [PubMed: 7663635]
156.
Travis LB, Li CY, Zhang ZN et al.: Hematopoietic malignancies and related disorders among
benzene-exposed workers in China. Leuk Lymphoma. 1994;14:91–9102.
CrossRef [PubMed: 7920231]
157.
Truemper E, Reyes de la Rocha S, Atkinson SD: Clinical characteristics, pathophysiology, and
management of hydrocarbon ingestion: case report and review of the literature. Pediatr Emerg
Care. 1987;3:187–193.
CrossRef [PubMed: 3313305]
158.
Truss CD, Killenberg PG: Treatment of carbon tetrachloride poisoning with hyperbaric
oxygen. Gastroenterology. 1982;82:767–769. [PubMed: 7060897]
159.
Tshiamo W: Paraffin (kerosene)* poisoning in under-five children: a problem of developing
countries. Int J Nurs Pract. 2009;15:140–144.
CrossRef [PubMed: 19531071]
160.
Tsou TJ, Hutson HR, Bear M et al.: De-solv-it for hot paving asphalt burn: case report. Acad
Emerg Med. 1996;3:88–89.
CrossRef [PubMed: 8749977]
161.
Turkel B, Egeli U: Analysis of chromosomal aberrations in shoe workers exposed long term to
benzene. Occup Environ Med. 1994;51:50–53.
CrossRef [PubMed: 8124464]
162.
Upreti RK, Das M, Shanker R: Dermal exposure to kerosene. Vet Hum Toxicol.1989;31:16–
20. [PubMed: 2523616]
163.
Vaziri ND, Smith PJ, Wilson A: Toxicity with intravenous injection of naphtha in man.Clin
Toxicol. 1980;16:335–343.
CrossRef [PubMed: 7398221]
164.
Victoria MS, Nangia BS: Hydrocarbon poisoning: a review. Pediatr Emerg Care.1987;3:184–186.
CrossRef [PubMed: 3313304]
165.
Vidic RD, Brantley SL, Vandenbossche JM et al.: Impact of shale gas development on regional
water quality. Science. 2013;340:1235009–.
CrossRef [PubMed: 23687049]
166.
Vigliani EC, Saita G: Benzene and Leukemia. N Engl J Med. 1964;271:872–876.
CrossRef [PubMed: 14185112]
167.
Violet JM, Downie DL, Nakisa RC et al.: Differential sensitivities of mammalian neuronal and
muscle nicotinic acetylcholine receptors to general anesthetics.Anesthesiology. 1997;86:866–874.
CrossRef [PubMed: 9105231]
168.
Voigts A, Kaufman CE Jr: Acidosis and other metabolic abnormalities associated with paint
sniffing. South Med J. 1983;76:443–447, 452.
CrossRef [PubMed: 6836357]
169.
Wahlberg P, Nyman D: Turpentine and thrombocytopenic purpura. Lancet.1969;2:215–216.
CrossRef [PubMed: 4183160]
170.
White DC, Halsey MJ: Effects of changes in temperature and pressure during experimental
anaesthesia. Br J Anaesth. 1974;46:196–201.
CrossRef [PubMed: 4851732]
171.
Widner LR, Goodwin SR, Berman LS et al.: Artificial surfactant for therapy in hydrocarbon-induced
lung injury in sheep. Crit Care Med. 1996;24:1524–1529.
CrossRef [PubMed: 8797626]
172.
Wirtschafter ZT, Cronyn MW: Free radical mechanism for solvent toxicity. Arch Environ
Health. 1964;9:186–191.
CrossRef [PubMed: 14155053]
173.
Wolfsdorf J: Experimental kerosene pneumonitis in primates: relevance to the therapeutic
management of childhood poisoning. Clin Exp Pharmacol Physiol.1976;3:539–544.
CrossRef [PubMed: 827406]
174.
Wolfsdorf J, Paed D: Kerosene intoxication: an experimental approach to the etiology of the CNS
manifestations in primates. J Pediatr. 1976;88:1037–1040.
CrossRef [PubMed: 818358]
175.
Wright PR, McMahon PB, Mueller DK, Clark ML: Groundwater-quality and quality-control data for
two monitoring wells near Pavillion, Wyoming, April and May
2012.http://pubs.usgs.gov/ds/718/DS718_508.pdf.
176.
Yakes B, Kelsey KT, Seitz T et al.: Occupational skin disease in newspaper pressroom workers. J
Occup Med. 1991;33:711–717.
CrossRef [PubMed: 1830898]
177.
Yamamura Y: n-Hexane polyneuropathy. Folia Psychiatr Neurol Jpn. 1969;23:45–57. [PubMed:
5820368]
178.
Zieserl E: Hydrocarbon ingestion and poisoning. Compr Ther. 1979;5:35–42. [PubMed: 455933]
179.
Zucker AR, Berger S, Wood LD: Management of kerosene-induced pulmonary injury. Crit Care
Med. 1986;14:303–304